Kolexia
Mounier Nicolas Oncologie médicale
Mounier Nicolas
Oncologie médicale
Hôpital De l'Archet
Nice, France
166 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Maladie de Hodgkin Lymphome B diffus à grandes cellules Lymphome malin non hodgkinien Infections à VIH Lymphome lié au SIDA Syndromes myélodysplasiques Leucémie aigüe myéloïde

Collaborateurs

Voir plus
Tilly Herve
Tilly Herve
Centre Henri-Becquerel, Rouen, France
Casasnovas Rene-Olivier
Casasnovas Rene-Olivier
Hôpital François Mitterrand, Dijon, France
Thieblemont Catherine
Thieblemont Catherine
Hôpital Saint-Louis, Paris, France
Haioun Corinne
Haioun Corinne
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
MundiPharma
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
R2-CHOP2: A Phase Ib/II Study of Escalating Doses of Revlimid in Association With R-CHOP (R2-CHOP) in the Treatment of B-cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   04 décembre 2023
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma: BEACOPP (4 Cycles Escalated + 4 Cycles Baseline) Versus ABVD (8 Cycles) In Stage III & IV Hodgkin's Lymphoma
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   08 novembre 2023
Identification and Clinical Characterization of CNS Relapse in DLBCL Patients across 19 Prospective Phase 2 and 3 Trials - a GLA/ DSHNHL and LYSA Collaboration
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Simplified IPI Including BCL2 Identifies IPI 3 Patients with Poor Prognosis - a GLA/ Dshnhl and Lysa Collaboration
65th ASH Annual Meeting Abstracts   02 novembre 2023
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma: A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage II-IV HIV-Associated Hodgkin Lymphoma
Essai Clinique (National Cancer Institute)   27 octobre 2023
Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.
The Lancet. Haematology   04 août 2023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis.
Blood advances   31 juillet 2023
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
Annals of hematology   21 mai 2022
Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
Cancer   04 octobre 2021
GENDER DISPARITIES IN QUALITY OF LIFE OF FRENCH PATIENTS ONE YEAR AFTER THE DIAGNOSIS OF LYMPHOMA. A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021